The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.

The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.

Icotinib is a small molecule targeting epidermal growth factor receptor tyrosine kinase, which shows non-inferior efficacy and better safety comparing to gefitinib in previous phase III trial. The present study was designed to further evaluate the efficacy and safety of icotinib in patients with adv...

Full description

Bibliographic Details
Main Authors: Xingsheng Hu, Li Zhang, Yuankai Shi, Caicun Zhou, Xiaoqing Liu, Dong Wang, Yong Song, Qiang Li, Jifeng Feng, Shukui Qin, Nong Xv, Jianying Zhou, Chunhong Hu, Shucai Zhang, Rongcheng Luo, Jie Wang, Fenlai Tan, Yinxiang Wang, Lieming Ding, Yan Sun
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4657981?pdf=render

Internet

http://europepmc.org/articles/PMC4657981?pdf=render

Similar Items